| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.809 | 0.003 | 0.809 | Alpha adrenoreceptor antagonist | 0.769 0.004 DBMET02355 0.769 0.004 DBMET02356 0.694 0.004 DBMET02358 0.113 0.05 DBMET02359 | ||
| 0.789 | 0.003 | 0.789 | Alpha 1 adrenoreceptor antagonist | 0.723 0.003 DBMET02355 0.723 0.003 DBMET02356 0.632 0.004 DBMET02358 0.092 0.047 DBMET02359 | ||
| 0.746 | 0.003 | 0.746 | Alpha 1a adrenoreceptor antagonist | 0.659 0.004 DBMET02355 0.659 0.004 DBMET02356 0.579 0.004 DBMET02358 0.065 0.054 DBMET02359 | ||
| 0.547 | 0.004 | 0.672 | Alpha 2a adrenoreceptor antagonist | 0.574 0.004 DBMET02355 0.574 0.004 DBMET02356 0.672 0.003 DBMET02358 0.151 0.022 DBMET02359 | DBMET02358 | |
| 0.542 | 0.003 | 0.542 | Alpha 2c adrenoreceptor antagonist | 0.504 0.004 DBMET02355 0.504 0.004 DBMET02356 0.539 0.003 DBMET02358 0.151 0.032 DBMET02359 | ||
| 0.562 | 0.032 | 0.562 | MAP kinase 1 inhibitor | 0.539 0.039 DBMET02355 0.539 0.039 DBMET02356 0.365 0.127 DBMET02358 0.475 0.064 DBMET02359 | ||
| 0.496 | 0.004 | 0.596 | Alpha 2 adrenoreceptor antagonist | 0.489 0.004 DBMET02355 0.489 0.004 DBMET02356 0.596 0.004 DBMET02358 0.149 0.027 DBMET02359 | DBMET02358 | |
| 0.493 | 0.004 | 0.647 | Alpha 2b adrenoreceptor antagonist | 0.454 0.004 DBMET02355 0.454 0.004 DBMET02356 0.647 0.003 DBMET02358 0.154 0.037 DBMET02359 | DBMET02358 | |
| 0.507 | 0.019 | 0.528 | Apoptosis antagonist | 0.528 0.017 DBMET02355 0.528 0.017 DBMET02356 0.207 0.17 DBMET02358 | DBMET02356 | |
| 0.49 | 0.004 | 0.535 | Protein kinase stimulant | 0.535 0.004 DBMET02355 0.535 0.004 DBMET02356 0.235 0.03 DBMET02358 0.119 0.094 DBMET02359 | DBMET02356 | |
| 0.438 | 0.004 | 0.586 | Alpha 1 adrenoreceptor agonist | 0.387 0.004 DBMET02355 0.387 0.004 DBMET02356 0.586 0.003 DBMET02358 0.092 0.019 DBMET02359 | DBMET02358 | |
| 0.427 | 0.004 | 0.454 | Alpha 1d adrenoreceptor antagonist | 0.309 0.005 DBMET02355 0.309 0.005 DBMET02356 0.454 0.004 DBMET02358 0.074 0.033 DBMET02359 | DBMET02358 | |
| 0.42 | 0.005 | 0.43 | Alpha 1b adrenoreceptor antagonist | 0.35 0.006 DBMET02355 0.35 0.006 DBMET02356 0.43 0.005 DBMET02358 0.085 0.042 DBMET02359 | DBMET02358 | |
| 0.398 | 0.008 | 0.499 | Antiadrenergic | 0.362 0.01 DBMET02355 0.362 0.01 DBMET02356 0.499 0.005 DBMET02358 | DBMET02358 | |
| 0.397 | 0.008 | 0.496 | Adrenaline antagonist | 0.36 0.01 DBMET02355 0.36 0.01 DBMET02356 0.496 0.005 DBMET02358 | DBMET02358 | |
| 0.378 | 0.036 | 0.463 | Hypoxia-inducible factor 1 alpha inhibitor | 0.463 0.018 DBMET02355 0.463 0.018 DBMET02356 0.431 0.023 DBMET02358 0.263 0.089 DBMET02359 | DBMET02356 | |
| 0.393 | 0.058 | 0.552 | Vasodilator, peripheral | 0.429 0.047 DBMET02355 0.429 0.047 DBMET02356 0.552 0.021 DBMET02358 0.273 0.112 DBMET02359 | DBMET02358 | |
| 0.347 | 0.017 | 0.543 | DNA methylase inhibitor | 0.406 0.01 DBMET02355 0.406 0.01 DBMET02356 0.543 0.005 DBMET02358 0.467 0.007 DBMET02359 | DBMET02358 | |
| 0.278 | 0.005 | 0.587 | Alpha adrenoreceptor agonist | 0.277 0.005 DBMET02355 0.277 0.005 DBMET02356 0.587 0.003 DBMET02358 0.105 0.026 DBMET02359 | DBMET02358 | |
| 0.323 | 0.07 | 0.44 | Calcium channel activator | 0.282 0.11 DBMET02355 0.282 0.11 DBMET02356 0.44 0.013 DBMET02358 0.336 0.06 DBMET02359 | DBMET02358 | |
| 0.246 | 0.007 | 0.287 | EphA2 antagonist | 0.22 0.01 DBMET02355 0.22 0.01 DBMET02356 0.263 0.005 DBMET02358 0.287 0.004 DBMET02359 | DBMET02359 | |
| 0.367 | 0.133 | 0.618 | Caspase 9 stimulant | 0.431 0.093 DBMET02355 0.431 0.093 DBMET02356 0.618 0.034 DBMET02358 0.478 0.069 DBMET02359 | DBMET02358 | |
| 0.279 | 0.05 | 0.532 | Cyclic AMP phosphodiesterase inhibitor | 0.301 0.041 DBMET02355 0.301 0.041 DBMET02356 0.532 0.005 DBMET02358 0.269 0.055 DBMET02359 | DBMET02358 | |
| 0.244 | 0.045 | 0.462 | Proto-oncogene tyrosine-protein kinase Fyn inhibitor | 0.236 0.049 DBMET02355 0.236 0.049 DBMET02356 0.413 0.011 DBMET02358 0.462 0.005 DBMET02359 | DBMET02359 | |
| 0.205 | 0.015 | 0.211 | Beta amyloid protein antagonist | 0.195 0.018 DBMET02355 0.195 0.018 DBMET02356 0.211 0.014 DBMET02358 0.203 0.016 DBMET02359 | DBMET02358 | |
| 0.207 | 0.022 | 0.481 | Ephrin antagonist | 0.177 0.03 DBMET02355 0.177 0.03 DBMET02356 0.289 0.01 DBMET02358 0.481 0.004 DBMET02359 | DBMET02359 | |
| 0.257 | 0.1 | 0.407 | Ca2+/calmodulin-dependent kinase II alpha inhibitor | 0.271 0.087 DBMET02355 0.271 0.087 DBMET02356 0.393 0.023 DBMET02358 0.407 0.02 DBMET02359 | DBMET02359 | |
| 0.22 | 0.07 | 0.44 | ErbB-1 antagonist | 0.208 0.081 DBMET02355 0.208 0.081 DBMET02356 0.363 0.02 DBMET02358 0.44 0.012 DBMET02359 | DBMET02359 | |
| 0.189 | 0.045 | 0.559 | RET inhibitor | 0.158 0.057 DBMET02355 0.158 0.057 DBMET02356 0.474 0.006 DBMET02358 0.559 0.005 DBMET02359 | DBMET02359 | |
| 0.169 | 0.038 | 0.347 | Epidermal growth factor receptor kinase inhibitor | 0.155 0.045 DBMET02355 0.155 0.045 DBMET02356 0.228 0.019 DBMET02358 0.347 0.006 DBMET02359 | DBMET02359 | |
| 0.126 | 0.005 | 0.126 | Phosphodiesterase VIII inhibitor | 0.118 0.006 DBMET02355 0.118 0.006 DBMET02356 0.069 0.055 DBMET02358 0.075 0.043 DBMET02359 | ||
| 0.168 | 0.05 | 0.184 | Hemostatic | 0.184 0.04 DBMET02355 0.184 0.04 DBMET02356 0.15 0.067 DBMET02358 | DBMET02356 | |
| 0.174 | 0.068 | 0.527 | Src kinase inhibitor | 0.165 0.074 DBMET02355 0.165 0.074 DBMET02356 0.367 0.016 DBMET02358 0.527 0.005 DBMET02359 | DBMET02359 | |
| 0.121 | 0.017 | 0.164 | mTOR complex 2 inhibitor | 0.117 0.019 DBMET02355 0.117 0.019 DBMET02356 0.145 0.009 DBMET02358 0.164 0.007 DBMET02359 | DBMET02359 | |
| 0.229 | 0.133 | 0.377 | Caspase 3 stimulant | 0.272 0.095 DBMET02355 0.272 0.095 DBMET02356 0.295 0.081 DBMET02358 0.377 0.051 DBMET02359 | DBMET02359 | |
| 0.173 | 0.078 | 0.224 | MAP kinase kinase 5 inhibitor | 0.162 0.109 DBMET02355 0.162 0.109 DBMET02356 0.224 0.014 DBMET02358 | DBMET02358 | |
| 0.108 | 0.016 | 0.27 | EphB4 antagonist | 0.083 0.022 DBMET02355 0.083 0.022 DBMET02356 0.17 0.009 DBMET02358 0.27 0.004 DBMET02359 | DBMET02359 | |
| 0.15 | 0.058 | 0.21 | Phosphodiesterase inhibitor | 0.112 0.09 DBMET02355 0.112 0.09 DBMET02356 0.21 0.032 DBMET02358 | DBMET02358 | |
| 0.178 | 0.091 | 0.348 | I kappa B kinase epsilon inhibitor | 0.169 0.1 DBMET02355 0.169 0.1 DBMET02356 0.298 0.015 DBMET02358 0.348 0.005 DBMET02359 | DBMET02359 | |
| 0.118 | 0.031 | 0.134 | mTOR complex 1 inhibitor | 0.111 0.042 DBMET02355 0.111 0.042 DBMET02356 0.111 0.041 DBMET02358 0.134 0.017 DBMET02359 | DBMET02359 | |
| 0.117 | 0.031 | 0.169 | ErbB-3 antagonist | 0.094 0.046 DBMET02355 0.094 0.046 DBMET02356 0.169 0.014 DBMET02358 0.135 0.023 DBMET02359 | DBMET02358 | |
| 0.185 | 0.099 | 0.391 | EphB2 antagonist | 0.155 0.125 DBMET02355 0.155 0.125 DBMET02356 0.391 0.018 DBMET02358 0.386 0.019 DBMET02359 | DBMET02358 | |
| 0.149 | 0.064 | 0.392 | Toll-Like receptor 9 antagonist | 0.392 0.005 DBMET02358 0.225 0.026 DBMET02359 | DBMET02358 | |
| 0.132 | 0.047 | 0.223 | Polo-like kinase-4 inhibitor | 0.118 0.059 DBMET02355 0.118 0.059 DBMET02356 0.223 0.011 DBMET02358 0.212 0.013 DBMET02359 | DBMET02358 | |
| 0.089 | 0.006 | 0.089 | Alpha 1b adrenoreceptor agonist | 0.084 0.007 DBMET02355 0.084 0.007 DBMET02356 0.08 0.008 DBMET02358 | ||
| 0.087 | 0.005 | 0.122 | Alpha 1L adrenoreceptor antagonist | 0.078 0.008 DBMET02355 0.078 0.008 DBMET02356 0.122 0.004 DBMET02358 0.063 0.018 DBMET02359 | DBMET02358 | |
| 0.11 | 0.03 | 0.408 | Glutamate release inhibitor | 0.094 0.054 DBMET02355 0.094 0.054 DBMET02356 0.257 0.004 DBMET02358 0.408 0.002 DBMET02359 | DBMET02359 | |
| 0.146 | 0.07 | 0.493 | Activin receptor-like kinase 2 inhibitor | 0.123 0.093 DBMET02355 0.123 0.093 DBMET02356 0.493 0.004 DBMET02358 0.321 0.009 DBMET02359 | DBMET02358 | |
| 0.134 | 0.065 | 0.452 | c-Src kinase inhibitor | 0.135 0.064 DBMET02355 0.135 0.064 DBMET02356 0.355 0.011 DBMET02358 0.452 0.005 DBMET02359 | DBMET02359 | |
| 0.107 | 0.038 | 0.107 | Leucine-rich repeat kinase 2 inhibitor | 0.076 0.061 DBMET02358 0.097 0.044 DBMET02359 | ||
| 0.107 | 0.042 | 0.231 | Insulin growth factor antagonist | 0.099 0.047 DBMET02355 0.099 0.047 DBMET02356 0.231 0.007 DBMET02358 0.194 0.012 DBMET02359 | DBMET02358 | |
| 0.182 | 0.12 | 0.217 | Vasodilator | 0.217 0.092 DBMET02355 0.217 0.092 DBMET02356 | DBMET02356 | |
| 0.101 | 0.041 | 0.223 | Insulin like growth factor 1 antagonist | 0.087 0.053 DBMET02355 0.087 0.053 DBMET02356 0.223 0.007 DBMET02358 0.184 0.012 DBMET02359 | DBMET02358 | |
| 0.102 | 0.043 | 0.317 | Epidermal growth factor antagonist | 0.093 0.051 DBMET02355 0.093 0.051 DBMET02356 0.191 0.016 DBMET02358 0.317 0.007 DBMET02359 | DBMET02359 | |
| 0.092 | 0.035 | 0.12 | 5 Hydroxytryptamine 1A antagonist | 0.12 0.026 DBMET02358 | DBMET02358 | |
| 0.079 | 0.024 | 0.332 | Alpha 2 adrenoreceptor agonist | 0.077 0.026 DBMET02355 0.077 0.026 DBMET02356 0.332 0.003 DBMET02358 0.089 0.019 DBMET02359 | DBMET02358 | |
| 0.13 | 0.078 | 0.424 | Lck kinase inhibitor | 0.111 0.092 DBMET02355 0.111 0.092 DBMET02356 0.236 0.028 DBMET02358 0.424 0.007 DBMET02359 | DBMET02359 | |
| 0.09 | 0.04 | 0.183 | ErbB-2 antagonist | 0.074 0.054 DBMET02355 0.074 0.054 DBMET02356 0.117 0.029 DBMET02358 0.183 0.011 DBMET02359 | DBMET02359 | |
| 0.085 | 0.036 | 0.144 | Phosphodiesterase 5A inhibitor | 0.073 0.047 DBMET02355 0.073 0.047 DBMET02356 0.144 0.012 DBMET02358 | DBMET02358 | |
| 0.062 | 0.014 | 0.096 | CC chemokine 4 receptor antagonist | 0.044 0.039 DBMET02355 0.044 0.039 DBMET02356 0.096 0.005 DBMET02358 0.053 0.023 DBMET02359 | DBMET02358 | |
| 0.162 | 0.114 | 0.326 | Platelet aggregation inhibitor | 0.234 0.059 DBMET02358 0.326 0.03 DBMET02359 | DBMET02359 | |
| 0.084 | 0.038 | 0.14 | Phosphodiesterase V inhibitor | 0.072 0.05 DBMET02355 0.072 0.05 DBMET02356 0.14 0.013 DBMET02358 | DBMET02358 | |
| 0.147 | 0.104 | 0.323 | Tumour necrosis factor antagonist | 0.323 0.014 DBMET02358 0.292 0.019 DBMET02359 | DBMET02358 | |
| 0.082 | 0.039 | 0.088 | MAP kinase 7 inhibitor | 0.075 0.062 DBMET02355 0.075 0.062 DBMET02356 0.088 0.023 DBMET02358 0.083 0.034 DBMET02359 | DBMET02358 | |
| 0.139 | 0.096 | 0.556 | Tyrosine kinase inhibitor | 0.356 0.034 DBMET02358 0.556 0.014 DBMET02359 | DBMET02359 | |
| 0.058 | 0.016 | 0.068 | DNA-dependent protein kinase inhibitor | 0.052 0.02 DBMET02355 0.052 0.02 DBMET02356 0.062 0.014 DBMET02358 0.068 0.012 DBMET02359 | DBMET02359 | |
| 0.118 | 0.076 | 0.168 | DNA repair enzyme inhibitor | 0.12 0.073 DBMET02355 0.12 0.073 DBMET02356 0.147 0.034 DBMET02358 0.168 0.019 DBMET02359 | DBMET02359 | |
| 0.087 | 0.048 | 0.233 | ErbB-4 antagonist | 0.184 0.014 DBMET02358 0.233 0.009 DBMET02359 | DBMET02359 | |
| 0.07 | 0.033 | 0.124 | Phosphatidylinositol kinase inhibitor | 0.057 0.044 DBMET02355 0.057 0.044 DBMET02356 0.124 0.015 DBMET02358 0.116 0.017 DBMET02359 | DBMET02358 | |
| 0.201 | 0.164 | 0.202 | Ca2+/calmodulin-dependent kinase IV inhibitor | 0.202 0.16 DBMET02358 | DBMET02358 | |
| 0.124 | 0.088 | 0.624 | Growth factor antagonist | 0.367 0.02 DBMET02358 0.624 0.006 DBMET02359 | DBMET02359 | |
| 0.063 | 0.028 | 0.11 | Phosphatidylinositol 3-kinase alpha inhibitor | 0.052 0.035 DBMET02355 0.052 0.035 DBMET02356 0.11 0.015 DBMET02358 0.082 0.021 DBMET02359 | DBMET02358 | |
| 0.06 | 0.028 | 0.093 | mTOR inhibitor | 0.049 0.039 DBMET02355 0.049 0.039 DBMET02356 0.093 0.013 DBMET02358 0.06 0.028 DBMET02359 | DBMET02358 | |
| 0.077 | 0.049 | 0.104 | 5 Hydroxytryptamine 1 antagonist | 0.104 0.036 DBMET02358 | DBMET02358 | |
| 0.043 | 0.017 | 0.104 | Phosphoglycerate kinase inhibitor | 0.054 0.013 DBMET02355 0.054 0.013 DBMET02356 0.046 0.015 DBMET02358 0.104 0.007 DBMET02359 | DBMET02359 | |
| 0.148 | 0.123 | 0.451 | Antimitotic | 0.175 0.1 DBMET02355 0.175 0.1 DBMET02356 0.33 0.037 DBMET02358 0.451 0.017 DBMET02359 | DBMET02359 | |
| 0.029 | 0.004 | 0.046 | Complement factor D inhibitor | 0.019 0.011 DBMET02355 0.019 0.011 DBMET02356 0.046 0.003 DBMET02358 0.02 0.01 DBMET02359 | DBMET02358 | |
| 0.139 | 0.118 | 0.386 | DNA methyltransferase I inhibitor | 0.191 0.074 DBMET02355 0.191 0.074 DBMET02356 0.297 0.027 DBMET02358 0.386 0.01 DBMET02359 | DBMET02359 | |
| 0.108 | 0.09 | 0.32 | TRKB antagonist | 0.275 0.013 DBMET02358 0.32 0.009 DBMET02359 | DBMET02359 | |
| 0.08 | 0.062 | 0.083 | Caspase 7 inhibitor | 0.083 0.054 DBMET02358 | DBMET02358 | |
| 0.076 | 0.066 | 0.329 | AXL receptor tyrosine kinase inhibitor | 0.148 0.018 DBMET02358 0.329 0.005 DBMET02359 | DBMET02359 | |
| 0.196 | 0.186 | 0.367 | Vasodilator, coronary | 0.218 0.166 DBMET02355 0.218 0.166 DBMET02356 0.367 0.048 DBMET02358 0.339 0.061 DBMET02359 | DBMET02358 | |
| 0.141 | 0.132 | 0.147 | P-glycoprotein inhibitor | 0.147 0.122 DBMET02355 0.147 0.122 DBMET02356 | DBMET02356 | |
| 0.152 | 0.142 | 0.445 | Ca2+/calmodulin-dependent kinase I alpha inhibitor | 0.264 0.054 DBMET02358 0.445 0.008 DBMET02359 | DBMET02359 | |
| 0.025 | 0.016 | 0.025 | 5 Hydroxytryptamine 4 agonist | |||
| 0.052 | 0.044 | 0.225 | Phosphatidylinositol 3-kinase delta inhibitor | 0.103 0.019 DBMET02358 0.225 0.006 DBMET02359 | DBMET02359 | |
| 0.034 | 0.027 | 0.04 | Adenosine uptake inhibitor | 0.04 0.011 DBMET02358 0.035 0.022 DBMET02359 | DBMET02358 | |
| 0.027 | 0.021 | 0.027 | Nicotinamide phosphoribosyltransferase inhibitor | |||
| 0.07 | 0.069 | 0.204 | Proto-oncogene tyrosine-protein kinase c-hck inhibitor | 0.07 0.068 DBMET02355 0.07 0.068 DBMET02356 0.157 0.012 DBMET02358 0.204 0.005 DBMET02359 | DBMET02359 | |
| 0.057 | 0.058 | 0.092 | 5 Hydroxytryptamine agonist | 0.092 0.036 DBMET02358 | DBMET02358 | |
| 0.071 | 0.072 | 0.14 | ALK inhibitor | 0.122 0.029 DBMET02358 0.14 0.022 DBMET02359 | DBMET02359 | |
| 0.055 | 0.059 | 0.245 | Fibroblast growth factor 2 antagonist | 0.162 0.009 DBMET02358 0.245 0.004 DBMET02359 | DBMET02359 | |
| 0.042 | 0.047 | 0.119 | Phosphatidylinositol 3-kinase beta inhibitor | 0.065 0.022 DBMET02358 0.119 0.01 DBMET02359 | DBMET02359 | |
| 0.082 | 0.088 | 0.194 | 5 Hydroxytryptamine 2 antagonist | 0.194 0.032 DBMET02358 | DBMET02358 | |
| 0.162 | 0.17 | 0.363 | RNA-directed DNA polymerase inhibitor | 0.193 0.11 DBMET02355 0.193 0.11 DBMET02356 0.172 0.149 DBMET02358 0.363 0.022 DBMET02359 | DBMET02359 | |
| 0.063 | 0.073 | 0.167 | 5 Hydroxytryptamine 2A antagonist | 0.167 0.024 DBMET02358 | DBMET02358 | |
| 0.13 | 0.14 | 0.134 | Lipocortins synthesis antagonist | 0.134 0.132 DBMET02355 0.134 0.132 DBMET02356 | DBMET02356 | |
| 0.045 | 0.055 | 0.08 | Phosphatidylinositol 3-kinase gamma inhibitor | 0.073 0.023 DBMET02358 0.08 0.02 DBMET02359 | DBMET02359 | |
| 0.076 | 0.087 | 0.242 | Granulocyte macrophage colony stimulating factor agonist | 0.084 0.065 DBMET02355 0.084 0.065 DBMET02356 0.144 0.006 DBMET02358 0.242 0.002 DBMET02359 | DBMET02359 | |
| 0.016 | 0.029 | 0.024 | Granulocyte colony stimulating factor receptor agonist | 0.023 0.005 DBMET02358 0.024 0.005 DBMET02359 | DBMET02359 | |
| 0.04 | 0.054 | 0.097 | Histamine H4 receptor antagonist | 0.097 0.005 DBMET02358 0.063 0.016 DBMET02359 | DBMET02358 | |
| 0.034 | 0.047 | 0.058 | Phosphodiesterase 3B inhibitor | 0.058 0.02 DBMET02358 | DBMET02358 | |
| 0.117 | 0.131 | 0.313 | Polo-like kinase-3 inhibitor | 0.25 0.024 DBMET02358 0.313 0.009 DBMET02359 | DBMET02359 | |
| 0.039 | 0.054 | 0.074 | 5 Hydroxytryptamine 2 agonist | 0.074 0.018 DBMET02358 | DBMET02358 | |
| 0.08 | 0.097 | 0.228 | Toll-Like receptor 3 antagonist | 0.125 0.026 DBMET02358 0.228 0.005 DBMET02359 | DBMET02359 | |
| 0.042 | 0.069 | 0.195 | Adenosine A2a receptor antagonist | 0.107 0.023 DBMET02358 0.195 0.01 DBMET02359 | DBMET02359 | |
| 0.047 | 0.074 | 0.198 | Heat shock protein 90 beta antagonist | 0.069 0.029 DBMET02355 0.069 0.029 DBMET02356 0.133 0.005 DBMET02358 0.198 0.004 DBMET02359 | DBMET02359 | |
| 0.087 | 0.117 | 0.185 | Activin receptor-like kinase 4 inhibitor | 0.185 0.017 DBMET02358 0.113 0.061 DBMET02359 | DBMET02358 | |
| 0.074 | 0.11 | 0.346 | Platelet activating factor antagonist | 0.168 0.036 DBMET02358 0.346 0.008 DBMET02359 | DBMET02359 | |
| 0.149 | 0.187 | 0.254 | MAP-kinase-activated kinase 5 inhibitor | 0.239 0.067 DBMET02358 0.254 0.057 DBMET02359 | DBMET02359 | |
| 0.065 | 0.105 | 0.393 | Platelet activating factor alpha antagonist | 0.192 0.018 DBMET02358 0.393 0.005 DBMET02359 | DBMET02359 | |
| 0.041 | 0.081 | 0.063 | Epithelial sodium channel blocker | 0.063 0.025 DBMET02358 0.063 0.025 DBMET02359 | DBMET02359 | |
| 0.076 | 0.118 | 0.276 | Protein kinase (CK1) delta inhibitor | 0.276 0.014 DBMET02358 0.25 0.017 DBMET02359 | DBMET02358 | |
| 0.1 | 0.146 | 0.485 | Ca2+/calmodulin-dependent kinase II gamma inhibitor | 0.286 0.037 DBMET02358 0.485 0.007 DBMET02359 | DBMET02359 | |
| 0.024 | 0.072 | 0.098 | Proto-oncogene tyrosine-protein kinase Met inhibitor | 0.076 0.018 DBMET02358 0.098 0.01 DBMET02359 | DBMET02359 | |
| 0.066 | 0.115 | 0.104 | Phosphodiesterase I inhibitor | 0.104 0.04 DBMET02359 | DBMET02359 | |
| 0.062 | 0.112 | 0.141 | Hepatocyte growth factor antagonist | 0.12 0.036 DBMET02358 0.141 0.025 DBMET02359 | DBMET02359 | |
| 0.069 | 0.119 | 0.081 | Transforming growth factor beta 3 antagonist | 0.081 0.06 DBMET02358 | DBMET02358 | |
| 0.054 | 0.106 | 0.086 | Macrophage migration inhibitory factor inhibitor | 0.086 0.044 DBMET02355 0.086 0.044 DBMET02356 | DBMET02356 | |
| 0.084 | 0.136 | 0.489 | Vascular endothelial growth factor 3 antagonist | 0.308 0.018 DBMET02358 0.489 0.005 DBMET02359 | DBMET02359 | |
| 0.037 | 0.091 | 0.092 | Phosphodiesterase III inhibitor | 0.092 0.027 DBMET02358 | DBMET02358 | |
| 0.015 | 0.068 | 0.028 | Potassium channel small-conductance Ca-activated activator | 0.028 0.026 DBMET02358 | DBMET02358 | |
| 0.036 | 0.094 | 0.19 | Adenosine A2 receptor antagonist | 0.102 0.027 DBMET02358 0.19 0.011 DBMET02359 | DBMET02359 | |
| 0.08 | 0.137 | 0.137 | CDC-like kinase 3 inhibitor | 0.096 0.089 DBMET02358 0.137 0.026 DBMET02359 | DBMET02359 | |
| 0.135 | 0.193 | 0.23 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.159 0.128 DBMET02355 0.159 0.128 DBMET02356 0.167 0.114 DBMET02358 0.23 0.052 DBMET02359 | DBMET02359 | |
| 0.053 | 0.111 | 0.088 | Adrenaline agonist | 0.084 0.053 DBMET02355 0.084 0.053 DBMET02356 0.088 0.048 DBMET02358 | DBMET02358 | |
| 0.121 | 0.179 | 0.442 | Ca2+/calmodulin-dependent kinase II beta inhibitor | 0.27 0.045 DBMET02358 0.442 0.011 DBMET02359 | DBMET02359 | |
| 0.067 | 0.126 | 0.225 | Glycogen synthase kinase-3 beta inhibitor | 0.225 0.024 DBMET02358 0.179 0.034 DBMET02359 | DBMET02358 | |
| 0.099 | 0.162 | 0.184 | MAP3K9 inhibitor | 0.119 0.116 DBMET02358 0.184 0.024 DBMET02359 | DBMET02359 | |
| 0.022 | 0.087 | 0.035 | ATR kinase inhibitor | 0.035 0.018 DBMET02358 | DBMET02358 | |
| 0.074 | 0.14 | 0.321 | Tubulin antagonist | 0.107 0.095 DBMET02355 0.107 0.095 DBMET02356 0.151 0.057 DBMET02358 0.321 0.017 DBMET02359 | DBMET02359 | |
| 0.056 | 0.122 | 0.174 | Inducible nitric-oxide synthase inhibitor | 0.174 0.011 DBMET02358 0.113 0.028 DBMET02359 | DBMET02358 | |
| 0.031 | 0.098 | 0.222 | Purinergic P2X2 antagonist | 0.089 0.035 DBMET02358 0.222 0.004 DBMET02359 | DBMET02359 | |
| 0.061 | 0.128 | 0.134 | 5 Hydroxytryptamine antagonist | 0.134 0.057 DBMET02358 | DBMET02358 | |
| 0.068 | 0.139 | 0.399 | Protein-tyrosine kinase Lyn inhibitor | 0.236 0.034 DBMET02358 0.399 0.007 DBMET02359 | DBMET02359 | |
| 0.111 | 0.184 | 0.438 | Ca2+/calmodulin-dependent protein kinase inhibitor | 0.343 0.03 DBMET02358 0.438 0.013 DBMET02359 | DBMET02359 | |
| 0.031 | 0.105 | 0.072 | Protein kinase C eta inhibitor | 0.072 0.028 DBMET02358 | DBMET02358 | |
| 0.044 | 0.118 | 0.11 | Phosphodiesterase IV inhibitor | 0.11 0.038 DBMET02358 | DBMET02358 | |
| 0.06 | 0.136 | 0.514 | Vascular endothelial growth factor antagonist | 0.182 0.044 DBMET02358 0.514 0.008 DBMET02359 | DBMET02359 | |
| 0.143 | 0.219 | 0.305 | DNA synthesis inhibitor | 0.2 0.123 DBMET02358 0.305 0.042 DBMET02359 | DBMET02359 | |
| 0.085 | 0.161 | 0.347 | Dual specificity tyrosine-phosphorylation regulated kinase 1B inhibitor | 0.16 0.066 DBMET02358 0.347 0.008 DBMET02359 | DBMET02359 | |
| 0.045 | 0.125 | 0.417 | Platelet activating factor beta antagonist | 0.199 0.025 DBMET02358 0.417 0.005 DBMET02359 | DBMET02359 | |
| 0.052 | 0.135 | 0.311 | Tyrosine-protein kinase receptor FLT3 inhibitor | 0.311 0.018 DBMET02358 0.276 0.022 DBMET02359 | DBMET02358 | |
| 0.079 | 0.164 | 0.389 | CDC-like kinase 1 inhibitor | 0.154 0.067 DBMET02358 0.389 0.005 DBMET02359 | DBMET02359 | |
| 0.058 | 0.145 | 0.21 | Glycogen synthase kinase-3 inhibitor | 0.21 0.029 DBMET02358 0.207 0.03 DBMET02359 | DBMET02358 | |
| 0.075 | 0.162 | 0.156 | Sodium channel blocker | 0.156 0.054 DBMET02358 | DBMET02358 | |
| 0.087 | 0.177 | 0.5 | CDC-like kinase 4 inhibitor | 0.292 0.034 DBMET02358 0.5 0.006 DBMET02359 | DBMET02359 | |
| 0.067 | 0.158 | 0.101 | Interleukin 12 antagonist | 0.101 0.052 DBMET02359 | DBMET02359 | |
| 0.024 | 0.115 | 0.056 | Bruton tyrosine kinase inhibitor | 0.056 0.039 DBMET02359 | DBMET02359 | |
| 0.047 | 0.139 | 0.152 | Interferon agonist | 0.152 0.01 DBMET02359 | DBMET02359 | |
| 0.09 | 0.184 | 0.592 | Clk dual-specificity kinase inhibitor | 0.291 0.041 DBMET02358 0.592 0.005 DBMET02359 | DBMET02359 | |
| 0.044 | 0.143 | 0.246 | Fibroblast growth factor 1 antagonist | 0.171 0.025 DBMET02358 0.246 0.009 DBMET02359 | DBMET02359 | |
| 0.071 | 0.171 | 0.302 | Folate antagonist | 0.107 0.053 DBMET02358 0.302 0.004 DBMET02359 | DBMET02359 | |
| 0.007 | 0.108 | 0.034 | Histamine H4 receptor agonist | 0.034 0.005 DBMET02358 0.021 0.011 DBMET02359 | DBMET02358 | |
| 0.03 | 0.131 | 0.108 | Toll-Like receptor 7 antagonist | 0.108 0.017 DBMET02358 | DBMET02358 | |
| 0.04 | 0.144 | 0.392 | Proto-oncogene tyrosine-protein kinase Kit inhibitor | 0.205 0.021 DBMET02358 0.392 0.007 DBMET02359 | DBMET02359 | |
| 0.021 | 0.126 | 0.366 | Dihydrofolate reductase inhibitor | 0.07 0.006 DBMET02358 0.366 0.002 DBMET02359 | DBMET02359 | |
| 0.104 | 0.21 | 0.232 | Interleukin agonist | 0.232 0.093 DBMET02358 | DBMET02358 | |
| 0.022 | 0.129 | 0.088 | Tyrosine-protein kinase EMT inhibitor | 0.054 0.043 DBMET02358 0.088 0.022 DBMET02359 | DBMET02359 | |
| 0.085 | 0.193 | 0.461 | Interleukin-1 receptor-associated protein kinase 1 inhibitor | 0.227 0.056 DBMET02358 0.461 0.008 DBMET02359 | DBMET02359 | |
| 0.038 | 0.146 | 0.094 | Protein kinase B beta inhibitor | 0.094 0.029 DBMET02358 | DBMET02358 | |
| 0.035 | 0.144 | 0.1 | ZAP-70 protein tyrosine kinase inhibitor | 0.067 0.051 DBMET02358 0.1 0.014 DBMET02359 | DBMET02359 | |
| 0.105 | 0.214 | 0.314 | Focal adhesion kinase 2 inhibitor | 0.28 0.023 DBMET02358 0.314 0.012 DBMET02359 | DBMET02359 | |
| 0.046 | 0.154 | 0.112 | Interleukin-1 receptor-associated protein kinase 4 inhibitor | 0.097 0.048 DBMET02358 0.112 0.037 DBMET02359 | DBMET02359 | |
| 0.038 | 0.146 | 0.106 | Protein kinase B alpha inhibitor | 0.106 0.027 DBMET02358 | DBMET02358 | |
| 0.102 | 0.212 | 0.463 | Death-associated protein kinase 3 inhibitor | 0.312 0.035 DBMET02358 0.463 0.009 DBMET02359 | DBMET02359 | |
| 0.155 | 0.268 | 0.426 | Toll-Like receptor agonist | 0.259 0.141 DBMET02358 0.426 0.051 DBMET02359 | DBMET02359 | |
| 0.041 | 0.154 | 0.076 | Phosphodiesterase 3A inhibitor | 0.076 0.062 DBMET02359 | DBMET02359 | |
| 0.042 | 0.158 | 0.517 | Vascular endothelial growth factor 2 antagonist | 0.176 0.041 DBMET02358 0.517 0.007 DBMET02359 | DBMET02359 | |
| 0.024 | 0.142 | 0.08 | Histamine agonist | 0.08 0.014 DBMET02358 0.079 0.014 DBMET02359 | DBMET02358 | |
| 0.039 | 0.157 | 0.104 | Interferon inducer | 0.104 0.011 DBMET02359 | DBMET02359 | |
| 0.153 | 0.272 | 0.374 | Toll-Like receptor 7 agonist | 0.253 0.145 DBMET02358 0.374 0.071 DBMET02359 | DBMET02359 | |
| 0.092 | 0.211 | 0.368 | MAP kinase kinase 2 inhibitor | 0.31 0.032 DBMET02358 0.368 0.017 DBMET02359 | DBMET02359 | |
| 0.035 | 0.156 | 0.345 | TIE-2 antagonist | 0.093 0.045 DBMET02358 0.345 0.005 DBMET02359 | DBMET02359 | |
| 0.031 | 0.153 | 0.096 | Phosphodiesterase 4D inhibitor | 0.096 0.039 DBMET02358 0.079 0.048 DBMET02359 | DBMET02358 | |
| 0.079 | 0.201 | 0.119 | Interleukin 2 antagonist | 0.119 0.047 DBMET02358 | DBMET02358 | |
| 0.056 | 0.179 | 0.182 | Protein kinase C zeta inhibitor | 0.14 0.023 DBMET02358 0.182 0.014 DBMET02359 | DBMET02359 | |
| 0.136 | 0.26 | 0.601 | Angiogenesis inhibitor | 0.261 0.115 DBMET02358 0.601 0.016 DBMET02359 | DBMET02359 | |
| 0.033 | 0.159 | 0.273 | Platelet growth factor antagonist | 0.119 0.03 DBMET02358 0.273 0.005 DBMET02359 | DBMET02359 | |
| 0.021 | 0.147 | 0.091 | Toll-Like receptor 8 antagonist | 0.091 0.012 DBMET02358 | DBMET02358 | |
| 0.066 | 0.192 | 0.487 | CDC-like kinase 2 inhibitor | 0.231 0.052 DBMET02358 0.487 0.006 DBMET02359 | DBMET02359 | |
| 0.036 | 0.162 | 0.347 | TIE antagonist | 0.094 0.046 DBMET02358 0.347 0.006 DBMET02359 | DBMET02359 | |
| 0.06 | 0.188 | 0.189 | Tyrosine-protein kinase receptor antagonist | 0.183 0.048 DBMET02358 0.189 0.045 DBMET02359 | DBMET02359 | |
| 0.053 | 0.182 | 0.077 | Phosphodiesterase 11A inhibitor | 0.075 0.072 DBMET02358 0.077 0.066 DBMET02359 | DBMET02359 | |
| 0.053 | 0.182 | 0.077 | Phosphodiesterase XI inhibitor | 0.075 0.072 DBMET02358 0.077 0.066 DBMET02359 | DBMET02359 | |
| 0.051 | 0.18 | 0.257 | Cyclin-dependent kinase 9 inhibitor | 0.192 0.024 DBMET02358 0.257 0.013 DBMET02359 | DBMET02359 | |
| 0.038 | 0.168 | 0.09 | Focal adhesion kinase 1 inhibitor | 0.075 0.055 DBMET02358 0.09 0.039 DBMET02359 | DBMET02359 | |
| 0.096 | 0.226 | 0.18 | Antiamyloidogenic | 0.159 0.135 DBMET02355 0.159 0.135 DBMET02356 0.18 0.114 DBMET02358 0.171 0.122 DBMET02359 | DBMET02358 | |
| 0.051 | 0.181 | 0.107 | 5 Hydroxytryptamine 2B antagonist | 0.107 0.075 DBMET02358 | DBMET02358 | |
| 0.004 | 0.137 | 0.018 | Cyclin T1 inhibitor | 0.018 0.012 DBMET02359 | DBMET02359 | |
| 0.038 | 0.17 | 0.076 | Secretase beta inhibitor | 0.076 0.041 DBMET02359 | DBMET02359 | |
| 0.017 | 0.151 | 0.154 | Adenosine A1 receptor antagonist | 0.06 0.039 DBMET02358 0.154 0.015 DBMET02359 | DBMET02359 | |
| 0.05 | 0.185 | 0.292 | Protein kinase (CK1) inhibitor | 0.288 0.019 DBMET02358 0.292 0.019 DBMET02359 | DBMET02359 | |
| 0.048 | 0.182 | 0.111 | Aminoacyl-tRNA synthetase inhibitor | 0.111 0.035 DBMET02359 | DBMET02359 | |
| 0.057 | 0.192 | 0.257 | Ribosomal protein S6 kinase inhibitor | 0.21 0.033 DBMET02358 0.257 0.019 DBMET02359 | DBMET02359 | |
| 0.14 | 0.275 | 0.246 | Alpha-glucosidase inhibitor | 0.246 0.19 DBMET02355 0.246 0.19 DBMET02356 | DBMET02356 | |
| 0.057 | 0.193 | 0.109 | Mucolytic | 0.109 0.066 DBMET02359 | DBMET02359 | |
| 0.079 | 0.216 | 0.144 | Sphingosine 1-phosphate receptor 2 agonist | 0.144 0.029 DBMET02358 | DBMET02358 | |
| 0.065 | 0.206 | 0.437 | Protein kinase C nu inhibitor | 0.265 0.032 DBMET02358 0.437 0.007 DBMET02359 | DBMET02359 | |
| 0.062 | 0.205 | 0.343 | Ca2+/calmodulin-dependent kinase II delta inhibitor | 0.203 0.045 DBMET02358 0.343 0.011 DBMET02359 | DBMET02359 | |
| 0.044 | 0.192 | 0.151 | Protein kinase C mu inhibitor | 0.151 0.026 DBMET02358 0.104 0.053 DBMET02359 | DBMET02358 | |
| 0.033 | 0.18 | 0.202 | Aurora-A kinase inhibitor | 0.142 0.043 DBMET02358 0.202 0.025 DBMET02359 | DBMET02359 | |
| 0.128 | 0.28 | 0.188 | Nootropic | 0.188 0.175 DBMET02358 | DBMET02358 | |
| 0.01 | 0.163 | 0.057 | Toll-Like receptor 8 agonist | 0.057 0.003 DBMET02359 | DBMET02359 | |
| 0.009 | 0.162 | 0.079 | 5 Hydroxytryptamine 2C agonist | 0.079 0.011 DBMET02358 | DBMET02358 | |
| 0.024 | 0.179 | 0.069 | Cytokine production stimulant | 0.069 0.008 DBMET02359 | DBMET02359 | |
| 0.053 | 0.208 | 0.495 | Dual specificity tyrosine-phosphorylation-regulated kinase 4 inhibitor | 0.242 0.038 DBMET02358 0.495 0.005 DBMET02359 | DBMET02359 | |
| 0.025 | 0.184 | 0.07 | Syk tyrosine kinase inhibitor | 0.064 0.055 DBMET02358 0.07 0.049 DBMET02359 | DBMET02359 | |
| 0.019 | 0.178 | 0.059 | Phosphodiesterase 4C inhibitor | 0.059 0.036 DBMET02358 | DBMET02358 | |
| 0.037 | 0.198 | 0.22 | Check point kinase 2 inhibitor | 0.157 0.029 DBMET02358 0.22 0.013 DBMET02359 | DBMET02359 | |
| 0.024 | 0.186 | 0.071 | Phosphodiesterase 4B inhibitor | 0.071 0.043 DBMET02358 | DBMET02358 | |
| 0.024 | 0.188 | 0.13 | Fibroblast growth factor 3 antagonist | 0.099 0.033 DBMET02358 0.13 0.02 DBMET02359 | DBMET02359 | |
| 0.015 | 0.181 | 0.074 | Alpha tubulin antagonist | 0.074 0.022 DBMET02359 | DBMET02359 | |
| 0.053 | 0.219 | 0.438 | Protein kinase (CK1) gamma 2 inhibitor | 0.156 0.047 DBMET02358 0.438 0.005 DBMET02359 | DBMET02359 | |
| 0.044 | 0.211 | 0.199 | Insulin receptor antagonist | 0.115 0.046 DBMET02358 0.199 0.015 DBMET02359 | DBMET02359 | |
| 0.038 | 0.206 | 0.237 | Vascular endothelial growth factor 1 antagonist | 0.122 0.053 DBMET02358 0.237 0.019 DBMET02359 | DBMET02359 | |
| 0.019 | 0.189 | 0.105 | Cyclin A2 inhibitor | 0.101 0.024 DBMET02358 0.105 0.023 DBMET02359 | DBMET02359 | |
| 0.074 | 0.245 | 0.198 | Cyclin-dependent kinase 8 inhibitor | 0.162 0.068 DBMET02358 0.198 0.037 DBMET02359 | DBMET02359 | |
| 0.066 | 0.237 | 0.341 | TRKC antagonist | 0.2 0.068 DBMET02358 0.341 0.017 DBMET02359 | DBMET02359 | |
| 0.03 | 0.203 | 0.069 | Polo-like kinase-2 inhibitor | 0.069 0.054 DBMET02358 | DBMET02358 | |
| 0.012 | 0.187 | 0.086 | Growth hormone secretagogue receptor antagonist | 0.086 0.009 DBMET02359 | DBMET02359 | |
| 0.024 | 0.203 | 0.051 | Alpha 1L adrenoreceptor agonist | 0.051 0.015 DBMET02358 | DBMET02358 | |
| 0.06 | 0.241 | 0.258 | Toll-Like receptor antagonist | 0.258 0.013 DBMET02358 0.133 0.069 DBMET02359 | DBMET02358 | |
| 0.021 | 0.203 | 0.051 | Potassium channel small-conductance Ca-activated blocker | 0.051 0.023 DBMET02358 0.051 0.024 DBMET02359 | DBMET02359 | |
| 0.038 | 0.221 | 0.278 | Aurora-B kinase inhibitor | 0.186 0.035 DBMET02358 0.278 0.017 DBMET02359 | DBMET02359 | |
| 0.046 | 0.231 | 0.117 | Alkylator | 0.117 0.071 DBMET02359 | DBMET02359 | |
| 0.061 | 0.246 | 0.533 | Protein kinase (CK1) gamma 1 inhibitor | 0.164 0.059 DBMET02358 0.533 0.004 DBMET02359 | DBMET02359 | |
| 0.119 | 0.307 | 0.424 | Immunomodulator | 0.424 0.038 DBMET02359 | DBMET02359 | |
| 0.009 | 0.2 | 0.104 | Beta tubulin antagonist | 0.104 0.021 DBMET02359 | DBMET02359 | |
| 0.017 | 0.209 | 0.094 | Cyclin A inhibitor | 0.088 0.027 DBMET02358 0.094 0.025 DBMET02359 | DBMET02359 | |
| 0.032 | 0.226 | 0.221 | Granulocyte macrophage colony stimulating factor antagonist | 0.128 0.048 DBMET02358 0.221 0.017 DBMET02359 | DBMET02359 | |
| 0.006 | 0.204 | 0.021 | O6-alkylguanine-DNA alkyltransferase inhibitor | 0.021 0.005 DBMET02359 | DBMET02359 | |
| 0.044 | 0.243 | 0.144 | MAP kinase 13 inhibitor | 0.136 0.043 DBMET02358 0.144 0.039 DBMET02359 | DBMET02359 | |
| 0.033 | 0.235 | 0.185 | Protein-tyrosine kinase (PTK, not ETK, WZC) inhibitor | 0.116 0.072 DBMET02358 0.185 0.032 DBMET02359 | DBMET02359 | |
| 0.033 | 0.235 | 0.184 | Abl kinase inhibitor | 0.116 0.072 DBMET02358 0.184 0.032 DBMET02359 | DBMET02359 | |
| 0.053 | 0.257 | 0.45 | Dual specificity tyrosine-phosphorylation regulated kinase 3 inhibitor | 0.265 0.038 DBMET02358 0.45 0.007 DBMET02359 | DBMET02359 | |
| 0.014 | 0.219 | 0.066 | Fibroblast growth factor 4 antagonist | 0.066 0.031 DBMET02359 | DBMET02359 | |
| 0.004 | 0.209 | 0.017 | 5 Lipoxygenase activating protein inhibitor | 0.017 0.006 DBMET02359 | DBMET02359 | |
| 0.063 | 0.271 | 0.407 | Protein kinase (CK1) gamma 3 inhibitor | 0.181 0.06 DBMET02358 0.407 0.006 DBMET02359 | DBMET02359 | |
| 0.04 | 0.249 | 0.118 | Breast cancer-resistant protein inhibitor | 0.089 0.067 DBMET02358 0.118 0.04 DBMET02359 | DBMET02359 | |
| 0.064 | 0.273 | 0.687 | Dyrk kinase inhibitor | 0.232 0.081 DBMET02358 0.687 0.005 DBMET02359 | DBMET02359 | |
| 0.044 | 0.255 | 0.123 | MAP kinase kinase 7 inhibitor | 0.097 0.016 DBMET02358 0.123 0.004 DBMET02359 | DBMET02359 | |
| 0.011 | 0.224 | 0.053 | Protein kinase (CK1) epsilon inhibitor | 0.053 0.011 DBMET02358 0.04 0.026 DBMET02359 | DBMET02358 | |
| 0.044 | 0.261 | 0.119 | Sodium channel (voltage-gated) blocker | 0.119 0.085 DBMET02358 | DBMET02358 | |
| 0.029 | 0.246 | 0.135 | Protein kinase B gamma inhibitor | 0.079 0.048 DBMET02358 0.135 0.021 DBMET02359 | DBMET02359 | |
| 0.04 | 0.26 | 0.36 | Proto-oncogene tyrosine-protein kinase Yes inhibitor | 0.116 0.085 DBMET02358 0.36 0.01 DBMET02359 | DBMET02359 | |
| 0.019 | 0.24 | 0.075 | Protein kinase (CaMK, MLCK, PhK, SNF, KIN, NIM1, MAPKAP, POLO, CHK, ULK, RSK-2nd domain) inhibitor | 0.075 0.055 DBMET02358 | DBMET02358 | |
| 0.043 | 0.264 | 0.116 | NADH dehydrogenase inhibitor | 0.08 0.075 DBMET02358 0.116 0.031 DBMET02359 | DBMET02359 | |
| 0.044 | 0.267 | 0.488 | Protein kinase (CK1) gamma inhibitor | 0.164 0.06 DBMET02358 0.488 0.005 DBMET02359 | DBMET02359 | |
| 0.026 | 0.251 | 0.119 | CDK/cyclin complex inhibitor | 0.081 0.067 DBMET02358 0.119 0.041 DBMET02359 | DBMET02359 | |
| 0.023 | 0.249 | 0.055 | Factor IXa inhibitor | 0.055 0.031 DBMET02359 | DBMET02359 | |
| 0.036 | 0.266 | 0.159 | Nitric-oxide synthase inhibitor | 0.157 0.02 DBMET02358 0.159 0.019 DBMET02359 | DBMET02359 | |
| 0.098 | 0.33 | 0.255 | 5 Hydroxytryptamine release stimulant | 0.255 0.087 DBMET02358 0.224 0.103 DBMET02359 | DBMET02358 | |
| 0.031 | 0.263 | 0.125 | Protein kinase C delta inhibitor | 0.125 0.034 DBMET02358 | DBMET02358 | |
| 0.015 | 0.247 | 0.094 | Macrophage colony-stimulating factor 1 receptor antagonist | 0.067 0.057 DBMET02358 0.094 0.031 DBMET02359 | DBMET02359 | |
| 0.04 | 0.276 | 0.108 | MAP kinase kinase 1 inhibitor | 0.108 0.047 DBMET02359 | DBMET02359 | |
| 0.013 | 0.25 | 0.054 | Adenosine deaminase inhibitor | 0.054 0.027 DBMET02359 | DBMET02359 | |
| 0.017 | 0.255 | 0.063 | 5 Hydroxytryptamine 3A antagonist | 0.063 0.051 DBMET02358 | DBMET02358 | |
| 0.016 | 0.255 | 0.111 | CDC7 inhibitor | 0.077 0.037 DBMET02358 0.111 0.019 DBMET02359 | DBMET02359 | |
| 0.052 | 0.291 | 0.663 | Dual specificity tyrosine-phosphorylation regulated kinase 1A inhibitor | 0.202 0.091 DBMET02358 0.663 0.005 DBMET02359 | DBMET02359 | |
| 0.067 | 0.308 | 0.217 | GABA C receptor rho-2 antagonist | 0.171 0.05 DBMET02358 0.217 0.021 DBMET02359 | DBMET02359 | |
| 0.016 | 0.258 | 0.06 | H+/K+-transporting ATPase inhibitor | 0.06 0.025 DBMET02359 | DBMET02359 | |
| 0.04 | 0.284 | 0.18 | Cyclin-dependent kinase 7 inhibitor | 0.134 0.073 DBMET02358 0.18 0.042 DBMET02359 | DBMET02359 | |
| 0.029 | 0.273 | 0.19 | Myeloperoxidase inhibitor | 0.088 0.053 DBMET02358 0.19 0.006 DBMET02359 | DBMET02359 | |
| 0.041 | 0.288 | 0.157 | Phosphodiesterase 7B inhibitor | 0.102 0.054 DBMET02358 0.157 0.019 DBMET02359 | DBMET02359 | |
| 0.01 | 0.26 | 0.097 | CDK1/cyclin B inhibitor | 0.097 0.026 DBMET02359 | DBMET02359 | |
| 0.036 | 0.286 | 0.113 | TRKA antagonist | 0.101 0.088 DBMET02358 0.113 0.073 DBMET02359 | DBMET02359 | |
| 0.135 | 0.388 | 0.258 | Apoptosis agonist | 0.258 0.205 DBMET02359 | DBMET02359 | |
| 0.06 | 0.313 | 0.156 | Hexokinase inhibitor | 0.156 0.072 DBMET02359 | DBMET02359 | |
| 0.026 | 0.28 | 0.173 | Cyclin-dependent kinase 2 inhibitor | 0.107 0.063 DBMET02358 0.173 0.03 DBMET02359 | DBMET02359 | |
| 0.035 | 0.29 | 0.177 | Protein kinase C gamma inhibitor | 0.142 0.036 DBMET02358 0.177 0.02 DBMET02359 | DBMET02359 | |
| 0.016 | 0.272 | 0.048 | Transforming growth factor beta 1 antagonist | 0.048 0.036 DBMET02359 | DBMET02359 | |
| 0.014 | 0.27 | 0.052 | Protein kinase C theta inhibitor | 0.052 0.05 DBMET02358 | DBMET02358 | |
| 0.025 | 0.282 | 0.133 | CDK2/cyclin A inhibitor | 0.082 0.077 DBMET02358 0.133 0.034 DBMET02359 | DBMET02359 | |
| 0.011 | 0.274 | 0.087 | CDK9/cyclin T1 inhibitor | 0.087 0.023 DBMET02359 | DBMET02359 | |
| 0.021 | 0.284 | 0.147 | Protein kinase A inhibitor | 0.082 0.058 DBMET02358 0.147 0.025 DBMET02359 | DBMET02359 | |
| 0.05 | 0.316 | 0.104 | T cell inhibitor | 0.104 0.021 DBMET02359 | DBMET02359 | |
| 0.019 | 0.286 | 0.066 | Protein kinase C alpha inhibitor | 0.066 0.049 DBMET02358 | DBMET02358 | |
| 0.067 | 0.334 | 0.192 | Tumour necrosis factor alpha release inhibitor | 0.192 0.116 DBMET02358 | DBMET02358 | |
| 0.024 | 0.292 | 0.059 | Phosphodiesterase 1A inhibitor | 0.059 0.043 DBMET02359 | DBMET02359 | |
| 0.014 | 0.285 | 0.06 | 5 Hydroxytryptamine 2A agonist | 0.06 0.047 DBMET02358 | DBMET02358 | |
| 0.081 | 0.358 | 0.163 | MAP kinase kinase 4 inhibitor | 0.163 0.04 DBMET02359 | DBMET02359 | |
| 0.035 | 0.316 | 0.141 | MAP kinase 12 inhibitor | 0.124 0.065 DBMET02358 0.141 0.048 DBMET02359 | DBMET02359 | |
| 0.016 | 0.299 | 0.108 | Rho-associated kinase I inhibitor | 0.108 0.027 DBMET02358 0.102 0.03 DBMET02359 | DBMET02358 | |
| 0.049 | 0.334 | 0.3 | Heat shock protein 90 antagonist | 0.3 0.01 DBMET02359 | DBMET02359 | |
| 0.1 | 0.385 | 0.137 | Heat shock protein 70 antagonist | 0.134 0.101 DBMET02358 0.137 0.085 DBMET02359 | DBMET02359 | |
| 0.068 | 0.354 | 0.147 | CF transmembrane conductance regulator agonist | 0.147 0.082 DBMET02359 | DBMET02359 | |
| 0.03 | 0.318 | 0.154 | MAP kinase kinase inhibitor | 0.154 0.049 DBMET02359 | DBMET02359 | |
| 0.014 | 0.304 | 0.088 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | 0.088 0.017 DBMET02359 | DBMET02359 | |
| 0.019 | 0.31 | 0.214 | Cyclin-dependent kinase 5 inhibitor | 0.108 0.068 DBMET02358 0.214 0.02 DBMET02359 | DBMET02359 | |
| 0.027 | 0.322 | 0.111 | Adenosine A3 receptor antagonist | 0.111 0.021 DBMET02359 | DBMET02359 | |
| 0.042 | 0.337 | 0.143 | Amyloid beta aggregation inhibitor | 0.143 0.114 DBMET02359 | DBMET02359 | |
| 0.106 | 0.403 | 0.273 | Nitric-oxide synthase stimulant | 0.192 0.104 DBMET02358 0.273 0.02 DBMET02359 | DBMET02359 | |
| 0.033 | 0.335 | 0.085 | Transcription factor RelA inhibitor | 0.085 0.013 DBMET02359 | DBMET02359 | |
| 0.016 | 0.322 | 0.062 | CDK2/cyclin E2 inhibitor | 0.062 0.059 DBMET02358 | DBMET02358 | |
| 0.032 | 0.341 | 0.131 | GABA C receptor rho-1 antagonist | 0.116 0.043 DBMET02358 0.131 0.032 DBMET02359 | DBMET02359 | |
| 0.067 | 0.376 | 0.209 | Neurotrophic factor enhancer | 0.209 0.068 DBMET02359 | DBMET02359 | |
| 0.028 | 0.338 | 0.176 | Cyclin-dependent kinase inhibitor | 0.119 0.074 DBMET02358 0.176 0.045 DBMET02359 | DBMET02359 | |
| 0.017 | 0.328 | 0.08 | Rho-associated kinase inhibitor | 0.08 0.046 DBMET02359 | DBMET02359 | |
| 0.007 | 0.322 | 0.098 | Raf kinase C inhibitor | 0.098 0.026 DBMET02359 | DBMET02359 | |
| 0.001 | 0.319 | 0.008 | Phosphoribosylglycinamide formyltransferase inhibitor | 0.008 0.005 DBMET02359 | DBMET02359 | |
| 0.007 | 0.326 | 0.107 | Raf kinase B inhibitor | 0.107 0.021 DBMET02359 | DBMET02359 | |
| 0.019 | 0.341 | 0.06 | Potassium channel (Ca-activated) blocker | 0.06 0.041 DBMET02359 | DBMET02359 | |
| 0.019 | 0.346 | 0.103 | 5 Hydroxytryptamine 3 agonist | 0.103 0.014 DBMET02358 | DBMET02358 | |
| 0.014 | 0.349 | 0.194 | Cyclin-dependent kinase 1 inhibitor | 0.106 0.062 DBMET02358 0.194 0.027 DBMET02359 | DBMET02359 | |
| 0.013 | 0.35 | 0.202 | Protein kinase (Mos, Mil/Raf, MEKK, RIPK, TESK, LIMK, IRAK, ILK, Activin/TGF-beta) inhibitor | 0.202 0.018 DBMET02359 | DBMET02359 | |
| 0.029 | 0.367 | 0.083 | Factor XII inhibitor | 0.083 0.06 DBMET02359 | DBMET02359 | |
| 0.057 | 0.395 | 0.14 | 3C-like protease (Human coronavirus) inhibitor | 0.14 0.121 DBMET02359 | DBMET02359 | |
| 0.024 | 0.364 | 0.13 | Polo-like kinase-1 inhibitor | 0.09 0.062 DBMET02358 0.13 0.025 DBMET02359 | DBMET02359 | |
| 0.058 | 0.401 | 0.291 | DNA damaging | 0.178 0.136 DBMET02358 0.291 0.061 DBMET02359 | DBMET02359 | |
| 0.005 | 0.352 | 0.062 | CDK2/cyclin E inhibitor | 0.062 0.041 DBMET02359 | DBMET02359 | |
| 0.045 | 0.392 | 0.14 | Aurora-C kinase inhibitor | 0.14 0.065 DBMET02359 | DBMET02359 | |
| 0.008 | 0.357 | 0.127 | Raf kinase inhibitor | 0.127 0.023 DBMET02359 | DBMET02359 | |
| 0.022 | 0.375 | 0.084 | MAP-kinase-activated kinase inhibitor | 0.084 0.056 DBMET02358 | DBMET02358 | |
| 0.023 | 0.376 | 0.122 | MAP kinase 9 inhibitor | 0.122 0.048 DBMET02359 | DBMET02359 | |
| 0.016 | 0.382 | 0.067 | Rho-associated kinase II inhibitor | 0.067 0.06 DBMET02359 | DBMET02359 | |
| 0.016 | 0.382 | 0.103 | Pim-3 kinase inhibitor | 0.103 0.043 DBMET02358 0.096 0.049 DBMET02359 | DBMET02358 | |
| 0.004 | 0.371 | 0.066 | Antimetabolite | 0.066 0.023 DBMET02359 | DBMET02359 | |
| 0.043 | 0.411 | 0.495 | Interleukin 4 antagonist | 0.495 0.004 DBMET02359 | DBMET02359 | |
| 0.004 | 0.373 | 0.033 | Cyclin E2 inhibitor | 0.033 0.016 DBMET02358 | DBMET02358 | |
| 0.007 | 0.381 | 0.067 | Adenosine A2b receptor antagonist | 0.067 0.019 DBMET02359 | DBMET02359 | |
| 0.122 | 0.499 | 0.248 | Calcium channel L-type activator | 0.244 0.212 DBMET02358 0.248 0.207 DBMET02359 | DBMET02359 | |
| 0.054 | 0.434 | 0.17 | MAP kinase 3 inhibitor | 0.17 0.043 DBMET02359 | DBMET02359 | |
| 0.007 | 0.388 | 0.018 | Tryptophan hydroxylase 1 inhibitor | 0.018 0.01 DBMET02359 | DBMET02359 | |
| 0.004 | 0.386 | 0.124 | Dihydropteroate synthase inhibitor | 0.124 0.004 DBMET02359 | DBMET02359 | |
| 0.015 | 0.405 | 0.071 | MAP-kinase-activated kinase 2 inhibitor | 0.071 0.056 DBMET02358 | DBMET02358 | |
| 0.009 | 0.404 | 0.063 | Cyclin A1 inhibitor | 0.063 0.032 DBMET02358 0.057 0.044 DBMET02359 | DBMET02358 | |
| 0.008 | 0.405 | 0.067 | Phosphodiesterase VII inhibitor | 0.067 0.038 DBMET02359 | DBMET02359 | |
| 0.07 | 0.472 | 0.148 | Neurotensin receptor agonist | 0.139 0.131 DBMET02358 0.148 0.107 DBMET02359 | DBMET02359 | |
| 0.009 | 0.412 | 0.171 | Protein kinase (CK2) alpha inhibitor | 0.113 0.067 DBMET02358 0.171 0.032 DBMET02359 | DBMET02359 | |
| 0.013 | 0.438 | 0.109 | S-adenosyl-L-methionine decarboxylase inhibitor | 0.109 0.009 DBMET02359 | DBMET02359 | |
| 0.016 | 0.443 | 0.092 | MAP kinase 8 inhibitor | 0.092 0.071 DBMET02359 | DBMET02359 | |
| 0.032 | 0.463 | 0.223 | Cytokine production inhibitor | 0.223 0.03 DBMET02359 | DBMET02359 | |
| 0.013 | 0.445 | 0.212 | Glycogen synthase kinase-3 alpha inhibitor | 0.115 0.088 DBMET02358 0.212 0.038 DBMET02359 | DBMET02359 | |
| 0.01 | 0.443 | 0.097 | Phenylalanine 4-hydroxylase inhibitor | 0.097 0.027 DBMET02359 | DBMET02359 | |
| 0.018 | 0.465 | 0.107 | GABA C receptor antagonist | 0.093 0.09 DBMET02358 0.107 0.068 DBMET02359 | DBMET02359 | |
| 0.03 | 0.477 | 0.181 | Interleukin 5 antagonist | 0.181 0.007 DBMET02359 | DBMET02359 | |
| 0.02 | 0.473 | 0.084 | Dual specificity tyrosine-phosphorylation regulated kinase 2 inhibitor | 0.084 0.058 DBMET02359 | DBMET02359 | |
| 0.007 | 0.46 | 0.113 | Protein kinase (CK2) inhibitor | 0.113 0.053 DBMET02359 | DBMET02359 | |
| 0.051 | 0.509 | 0.256 | Superoxide dismutase inhibitor | 0.256 0.071 DBMET02358 0.218 0.1 DBMET02359 | DBMET02358 | |
| 0.008 | 0.466 | 0.04 | 5 Hydroxytryptamine 2B agonist | 0.04 0.025 DBMET02358 | DBMET02358 | |
| 0.009 | 0.469 | 0.045 | Tryptophan 5 hydroxylase inhibitor | 0.045 0.008 DBMET02359 | DBMET02359 | |
| 0.043 | 0.505 | 0.177 | ATPase inhibitor | 0.177 0.061 DBMET02359 | DBMET02359 | |
| 0.036 | 0.5 | 0.092 | Adenylate kinase inhibitor | 0.092 0.083 DBMET02359 | DBMET02359 | |
| 0.019 | 0.483 | 0.372 | Aryl hydrocarbon receptor agonist | 0.372 0.043 DBMET02359 | DBMET02359 | |
| 0.044 | 0.521 | 0.225 | Transcription factor NF kappa B inhibitor | 0.225 0.147 DBMET02359 | DBMET02359 | |
| 0.032 | 0.519 | 0.154 | Succinate dehydrogenase inhibitor | 0.154 0.106 DBMET02359 | DBMET02359 | |
| 0.017 | 0.526 | 0.115 | 5 Hydroxytryptamine 3A agonist | 0.115 0.06 DBMET02358 | DBMET02358 | |
| 0.039 | 0.552 | 0.154 | Ca2+/calmodulin-dependent protein kinase kinase B inhibitor | 0.154 0.065 DBMET02359 | DBMET02359 | |
| 0.006 | 0.521 | 0.088 | Xanthine dehydrogenase inhibitor | 0.088 0.02 DBMET02359 | DBMET02359 | |
| 0.011 | 0.532 | 0.043 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | 0.043 0.026 DBMET02359 | DBMET02359 | |
| 0.003 | 0.526 | 0.073 | Fructose-1,6-bisphosphatase inhibitor | 0.073 0.011 DBMET02359 | DBMET02359 | |
| 0.002 | 0.531 | 0.026 | Fructose-1,6-bisphosphatase 1 inhibitor | 0.026 0.011 DBMET02359 | DBMET02359 | |
| 0.073 | 0.603 | 0.471 | 5 Hydroxytryptamine release inhibitor | 0.471 0.043 DBMET02359 | DBMET02359 | |
| 0.009 | 0.539 | 0.075 | CDK1/cyclin B1 inhibitor | 0.075 0.043 DBMET02359 | DBMET02359 | |
| 0.015 | 0.546 | 0.086 | GABA C receptor agonist | 0.086 0.084 DBMET02359 | DBMET02359 | |
| 0.027 | 0.56 | 0.207 | Aldehyde oxidase inhibitor | 0.207 0.101 DBMET02359 | DBMET02359 | |
| 0.013 | 0.552 | 0.113 | Histamine N-methyltransferase inhibitor | 0.113 0.035 DBMET02359 | DBMET02359 | |
| 0.058 | 0.602 | 0.377 | GABA C receptor rho-3 antagonist | 0.277 0.132 DBMET02358 0.377 0.072 DBMET02359 | DBMET02359 | |
| 0.002 | 0.555 | 0.033 | Endothelial nitric-oxide synthase inhibitor | 0.033 0.019 DBMET02359 | DBMET02359 | |
| 0.021 | 0.577 | 0.061 | Immunoglobulin Fc receptor antagonist | 0.061 0.023 DBMET02359 | DBMET02359 | |
| 0.05 | 0.607 | 0.204 | Growth factor agonist | 0.204 0.059 DBMET02359 | DBMET02359 | |
| 0.026 | 0.589 | 0.229 | Peroxidase inhibitor | 0.229 0.052 DBMET02359 | DBMET02359 | |
| 0.018 | 0.583 | 0.085 | Falcipain 2 inhibitor | 0.085 0.064 DBMET02359 | DBMET02359 | |
| 0.016 | 0.583 | 0.155 | Immunostimulant | 0.155 0.15 DBMET02359 | DBMET02359 | |
| 0.008 | 0.576 | 0.068 | AICAR transformylase inhibitor | 0.068 0.01 DBMET02359 | DBMET02359 | |
| 0.042 | 0.61 | 0.386 | Histamine release inhibitor | 0.386 0.083 DBMET02359 | DBMET02359 | |
| 0.018 | 0.587 | 0.086 | Falcipain inhibitor | 0.086 0.066 DBMET02359 | DBMET02359 | |
| 0.009 | 0.579 | 0.127 | Potassium channel (ATP-sensitive) blocker | 0.127 0.007 DBMET02359 | DBMET02359 | |
| 0.008 | 0.605 | 0.324 | LIM domain kinase 1 inhibitor | 0.142 0.107 DBMET02358 0.324 0.016 DBMET02359 | DBMET02359 | |
| 0.076 | 0.678 | 0.2 | 5 Hydroxytryptamine uptake stimulant | 0.2 0.152 DBMET02359 | DBMET02359 | |
| 0.004 | 0.609 | 0.076 | Thymidylate synthase inhibitor | 0.076 0.009 DBMET02359 | DBMET02359 | |
| 0.009 | 0.623 | 0.072 | Cyclin D1 inhibitor | 0.072 0.026 DBMET02359 | DBMET02359 | |
| 0.012 | 0.634 | 0.072 | GABA B receptor agonist | 0.072 0.064 DBMET02359 | DBMET02359 | |
| 0.009 | 0.631 | 0.11 | I kappa B kinase inhibitor | 0.11 0.031 DBMET02359 | DBMET02359 | |
| 0.017 | 0.646 | 0.096 | DOPA decarboxylase inhibitor | 0.096 0.085 DBMET02359 | DBMET02359 | |
| 0.013 | 0.651 | 0.112 | I kappa B kinase 1 inhibitor | 0.112 0.017 DBMET02359 | DBMET02359 | |
| 0.003 | 0.646 | 0.036 | CDK5/p25 inhibitor | 0.036 0.035 DBMET02359 | DBMET02359 | |
| 0.019 | 0.672 | 0.138 | Antipruritic | 0.138 0.109 DBMET02359 | DBMET02359 | |
| 0.011 | 0.672 | 0.193 | Heat shock protein 90 alpha antagonist | 0.193 0.054 DBMET02359 | DBMET02359 | |
| 0.005 | 0.666 | 0.065 | Cyclin B1 inhibitor | 0.065 0.037 DBMET02359 | DBMET02359 | |
| 0.077 | 0.746 | 0.295 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.295 0.22 DBMET02359 | DBMET02359 | |
| 0.005 | 0.674 | 0.058 | Cyclin B inhibitor | 0.058 0.034 DBMET02359 | DBMET02359 | |
| 0.018 | 0.688 | 0.124 | Carbonic anhydrase XV inhibitor | 0.124 0.043 DBMET02359 | DBMET02359 | |
| 0.021 | 0.698 | 0.082 | D-Ala-D-Ala ligase inhibitor | 0.082 0.064 DBMET02359 | DBMET02359 | |
| 0.005 | 0.686 | 0.054 | Cyclin B2 inhibitor | 0.054 0.041 DBMET02359 | DBMET02359 | |
| 0.011 | 0.695 | 0.139 | Nav1.6 sodium channel blocker | 0.139 0.067 DBMET02359 | DBMET02359 | |
| 0.013 | 0.718 | 0.107 | Electrolyte absorption antagonist | 0.107 0.049 DBMET02359 | DBMET02359 | |
| 0.014 | 0.735 | 0.093 | HIV-1 integrase (Overall Integration) inhibitor | 0.093 0.062 DBMET02359 | DBMET02359 | |
| 0.003 | 0.732 | 0.039 | Histamine H2 receptor agonist | 0.039 0.035 DBMET02359 | DBMET02359 | |
| 0.006 | 0.736 | 0.038 | Glutamate (mGluR group III) agonist | 0.038 0.036 DBMET02359 | DBMET02359 | |
| 0.01 | 0.763 | 0.085 | Xanthine oxidase inhibitor | 0.085 0.08 DBMET02359 | DBMET02359 | |
| 0.01 | 0.787 | 0.102 | Interleukin 8 antagonist | 0.102 0.092 DBMET02359 | DBMET02359 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |